article · Sohag Medical Journal
Background: Muscular dystrophies, which are characterized by progressive muscle atrophy, are a heterogeneous group of inherited muscular diseases. Aim of work: Clinical aspects in children with Duchenne muscular dystrophy at Sohag University Hospital. Subjects and methods: This was cross-sectional research performed at the pediatric department and pediatric neurology unit, Sohag University Hospital over two years, from 2022 to 2023. Results: In our research, 53 children had a confirmed Duchenne diagnosis, divided into two groups according to ambulation: Group A: 33 (62.3%) ambulant children. Group B: 20 (37.7%) non-ambulant children. The verbal and total IQ tests were significantly higher in group A than group B. The EF (ejection fraction) and FS (fraction shortening) were significantly higher in group A than group B. All patients had hyporeflexia. Regarding muscle state, there was calf hypertrophy in 33 (100%) of group A and 3 (15%) in group B, and Muscle wasting in 17 (85%) of group B compared to no cases in group A, which was significantly different. As regard skeletal abnormalities, 27 (81.8%) patients in group A had lordosis compared to 4 (20%) patients in group B, while 4 (20%) had scoliosis, 5 (25% had scoliosis and joint stiffness), and 5 (25% had joint stiffness) in group B, with no cases in group A with a statistically significant difference. Functional ability (North Star score) was positively correlated with young age. Conclusion: Younger age and ambulant status were associated with better cardiac, muscular, skeletal, cognitive, functional outcomes and abilities in Duchenne muscular dystrophy patients.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/smj.2024.278924.1460
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.